| PRD_002324 | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | Formula: | C62 H111 N11 O13 | Definition date: | 2018-09-12 | Last modified: | 2018-09-12 |
|
| PRD_002318 | Name: | SRC2-BCP1 | Formula: | C64 H109 N19 O15 | Definition date: | 2018-07-25 | Last modified: | 2018-07-25 |
|
| PRD_002227 | Name: | (2R)-N-[2-[[(2S)-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]-5-oxidanylidene-1,2-dihydropyrrole-2-carboxamide | Formula: | C13 H20 N6 O4 | Definition date: | 2018-07-11 | Last modified: | 2018-07-11 |
|
| PRD_002229 | Name: | (2R)-N-[2-[[(2S)-1-[[4-[bis(oxidanyl)amino]phenyl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]-5-oxidanylidene-pyrrolidine-2-carboxamide | Formula: | C19 H28 N8 O6 | Definition date: | 2018-07-11 | Last modified: | 2018-07-11 |
|
| PRD_002279 | Name: | N-acetyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl-N-[(1R,4S,7S,10S,19S,22S,25S,28R)-28-{[(2R)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl}-25-(3-amino-3-oxopropyl)-4-[(1H-imidazol-3-ium-4-yl)methyl]-10,19-dimethyl-7,22-bis(2-methylpropyl)-3,6,9,20,23,26,30,36-octaoxo-2,5,8,21,24,27,31,37-octaazabicyclo[17.16.2]heptatriacontan-31-ium-10-yl]-6-azaniumyl-L-norleucinamide | Formula: | C64 H109 N19 O15 | Definition date: | 2018-06-13 | Last modified: | 2018-06-13 |
|
| PRD_002302 | Name: | benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate | Formula: | C37 H55 N7 O7 | Definition date: | 2018-06-13 | Last modified: | 2018-06-13 |
|
| PRD_002308 | Name: | DAMGO | Formula: | C26 H35 N5 O6 | Definition date: | 2018-06-13 | Last modified: | 2018-06-13 |
|
| PRD_002303 | Name: | [(3-{(3S,6S,9S,15R,20aS)-15-[(N-acetyl-L-phenylalanyl)amino]-3-(cyclohexylmethyl)-6-[(1H-indol-3-yl)methyl]-1,4,7,10,16-pentaoxoicosahydropyrrolo[1,2-a][1,4,7,10,13]pentaazacyclooctadecin-9-yl}propyl)amino](amino)methaniminium | Formula: | C47 H66 N11 O7 | Definition date: | 2018-05-30 | Last modified: | 2018-05-30 |
|
| PRD_002285 | Name: | N~2~-[(2S)-2-{[3-(6-chloro-1,3-benzothiazol-2-yl)-N-propanoyl-L-alanyl]amino}-2-cyclopentylacetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-N~6~,N~6~-dimethyl-L-lysinamide | Formula: | C37 H49 Cl N6 O5 S | Definition date: | 2018-02-28 | Last modified: | 2023-11-03 |
|
| PRD_002301 | Formula: | C35 H47 N8 O11 S | Definition date: | 2018-01-31 | Last modified: | 2018-01-31 |
|
| PRD_002263 | Name: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide | Formula: | C31 H47 N5 O4 S | Definition date: | 2017-11-01 | Last modified: | 2017-11-01 |
|
| PRD_002282 | Name: | (3S,6S,9S,15aR)-6,9-dibenzyl-3-{6,6-dihydroxy-6-[(2S)-oxiran-2-yl]hexyl}octahydro-2H-pyrido[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10(3H,12H)-tetrone | Formula: | C34 H44 N4 O7 | Definition date: | 2017-09-13 | Last modified: | 2023-11-03 |
|
| PRD_002277 | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | Formula: | C64 H93 N23 O25 S3 | Definition date: | 2017-08-30 | Last modified: | 2017-12-15 |
|
| PRD_002239 | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | Formula: | C32 H57 N7 O7 S | Definition date: | 2017-08-02 | Last modified: | 2023-11-03 |
|
| PRD_000041 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-4-(2-(3-AMINOPROPYLAMINO)ETHOXY)-5-((1R,2R,3S,5R,6S)-3,5-DIAM
INO-2-((2S,3R,4R,5S,6R)-3-AMINO-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(
HYDROXYMETHYL)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C28 H57 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000042 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R,4R,5S,6R)-3-AMINO-4
,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(HYDROXYMETHYL)-4-(2-((R)-PIPERIDI
N-3-YLMETHYLAMINO)ETHOXY)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C31 H61 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000043 | Name: | DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162 | Formula: | C37 H65 N7 O16 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_002270 | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | Formula: | C28 H44 N8 O5 | Definition date: | 2017-06-28 | Last modified: | 2020-06-21 |
|
| PRD_002274 | Name: | N-[(6aR,12R,15aR,17R,21R,23aR)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-Nalpha-[(2E)-pent-2-enoyl]-L-phenylalaninamide | Formula: | C37 H50 N6 O8 | Definition date: | 2017-06-21 | Last modified: | 2017-06-21 |
|
| PRD_002275 | Formula: | C35 H59 N14 O13 | Definition date: | 2017-06-14 | Last modified: | 2017-12-15 |
|
| PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
| PRD_002240 | Name: | 18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C30 H44 N4 O6 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002241 | Name: | 3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | Formula: | C30 H42 N4 O6 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002245 | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C35 H46 N4 O7 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002246 | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C36 H48 N4 O7 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|